Skip to main content
. 2020 Jul 29;37(9):3985–3999. doi: 10.1007/s12325-020-01445-4

Table 2.

Burdens in patients with hip and/or knee OA in the total population (US and EU cohorts; N = 2170) by pain intensity and opioid use

No/mild pain without opioid use (n = 859) No/mild pain with opioid use (n = 221) Moderate/severe pain without opioid use (n = 663) Moderate/severe pain with opioid use (n = 427)
Physical function
 Mobility limitation (n = 2094) 432 (52.4) 149 (69.0)c 498 (78.2)c 362 (87.0)c
 Need for walking aida (n = 1427) 129 (30.0) 67 (45.3)c 225 (46.1)c 243 (67.3)c
 Need for help with daily activities (n = 2059) 83 (10.2) 46 (21.4)c 183 (29.3)c 197 (48.9)c
 Suffered a fall (n = 2115) 148 (17.6) 47 (21.7) 195 (30.6)c 189 (45.3)c
Treatment needs
 Use of ≥ 3 treatment regimens for OA (n = 1965) 102 (13.9) 90 (40.7)c 132 (22.7)c 214 (50.1)c
 Dissatisfaction with treatmentb (n = 1859) 40 (5.8) 22 (10.6)c 144 (25.5)c 153 (38.1)c
Comorbidity (N = 2170)
 Any cardiovascular condition 421 (49.0) 151 (68.3)c 379 (57.2)c 308 (72.1)c
 Hypertension 388 (45.2) 142 (64.3)c 355 (53.5)c 283 (66.3)c
 Depression or anxiety 129 (15.0) 49 (22.2)c 146 (22.0)c 147 (34.4)c
 Osteoporosis 51 (5.9) 22 (10.0)c 67 (10.1)c 65 (15.2)c
 Chronic low back pain 52 (6.1) 25 (11.3)c 85 (12.8)c 93 (21.8)c

Values are the number (%)

EU European Union, OA osteoarthritis

aAmong those who reported mobility limitation

bAmong those currently treated

cp < 0.05 versus no/mild pain and no opioid use